Objectives

The primary objective of the GAPP Project is to assess gabapentin side effects and efficacy in children from 3 months of age to less than 18 years of age testing a new paediatric oral liquid formulation.

The specific objectives are:

 

Consortium
Newsletter

Please subscribe to the GAPP Project newsletter to receive our latest updates.